Menu Close

Articles on Quality-adjusted life years (QALY)

Displaying all articles

The PBAC must make tough decisions about which cancer drugs to subsidise. Eric Gaillard/Reuters

New cancer drugs are very expensive - here’s how we work out value for our money

Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can’t afford all of them. How then are decisions about which drugs to subsidise made?